- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01463020
Behavioural Activation-Based Treatment Administered Through Smartphone
June 18, 2013 updated by: Gerhard Andersson, Linkoeping University
Behavioural Activation-Based Guided Self-Help Treatment Administered Through a Smartphone Application
The objective is to test the effects of a smartphone-delivered behavioural activation treatment.
Also, a moderator analysis of low and high severity of depressive symptoms will be made.
We expect the behavioural activation intervention to be superior to the mindfulness intervention for the participants suffering from high severity of depressive symptoms - and the mindfulness intervention to be better or at least as good as the behavioural activation intervention for the participants suffering from low severity of depressive symptoms.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
Major depression is expected to be the disorder with the highest disease burden in high-income countries by the year 2030.
The efficacy of behavioural activation in the treatment of major depressive disorders has been established in a number of studies over the last four decades.
Furthermore, behavioural activation is an intervention that can largely benefit from the use of new mobile technologies (e.g.
smartphones).
One important feature of mobile technology is the possibility for the therapist to reach the patient between sessions and thus create direct incentives for behavioural activation in everyday life.
Therefore, developing smartphone-based behavioural activation interventions might be a way to develop a cost-effective treatment for people suffering from major depressive disorders.
Study Type
Interventional
Enrollment (Actual)
81
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Östergötland
-
Linköping, Östergötland, Sweden
- Linköping University
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 65 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- depressive symptoms according to DSM-IV
- have access to the Internet and a smartphone
- have good knowledge of the Swedish language
Exclusion Criteria:
- recent (during last 6 weeks) change in psychiatric medication
- presently in any other psychological treatment
- severe depression
- suicidal ideation
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Smartphone delivered BA
|
A 8 week behavioural activation therapy delivered through smartphone
|
|
Active Comparator: Smartphone delivered mindfulness
|
A 8 week mindfulness intervention delivered through smartphone
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Patient Health Questionnaire (PHQ-9)- Change from baseline
Time Frame: Two weeks pre treatment, two weeks post treatment, six months and 12 months post treatment
|
Change from baseline in anxiety symptoms two weeks post treatment, at six months and at 12 months post treatment.
|
Two weeks pre treatment, two weeks post treatment, six months and 12 months post treatment
|
|
Beck Depression Inventory (BDI)- Change from baseline
Time Frame: Two weeks pre treatment, two weeks post treatment, six months and 12 months post treatment
|
Change from baseline in anxiety symptoms two weeks post treatment, at six months and at 12 months post treatment.
|
Two weeks pre treatment, two weeks post treatment, six months and 12 months post treatment
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Quality of Life Inventory (QOLI)- Change from baseline
Time Frame: Two weeks pre treatment, two weeks post treatment, six months and 12 months post treatment
|
Change from baseline in anxiety symptoms two weeks post treatment, at six months and at 12 months post treatment.
|
Two weeks pre treatment, two weeks post treatment, six months and 12 months post treatment
|
|
Acceptance & Action Questionnaire (AAQ)- Change from baseline
Time Frame: Two weeks pre treatment, two weeks post treatment, six months and 12 months post treatment
|
Change from baseline in anxiety symptoms two weeks post treatment, at six months and at 12 months post treatment.
|
Two weeks pre treatment, two weeks post treatment, six months and 12 months post treatment
|
|
Beck Anxiety Inventory (BAI)- Change from baseline
Time Frame: Two weeks pre treatment, two weeks post treatment, six months and 12 months post treatment
|
Change from baseline in anxiety symptoms two weeks post treatment, at six months and at 12 months post treatment.
|
Two weeks pre treatment, two weeks post treatment, six months and 12 months post treatment
|
|
Trimbos and iMTA questionnaire on Costs associated with Psychiatric illness (TIC-P)- Change from baseline
Time Frame: Two weeks pre treatment and at six months post treatment.
|
Change from baseline in health cost burden and at six months post treatment.
|
Two weeks pre treatment and at six months post treatment.
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Study Director: Gerhard Andersson, Professor, Linkoeping University
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
General Publications
- Ly KH, Truschel A, Jarl L, Magnusson S, Windahl T, Johansson R, Carlbring P, Andersson G. Behavioural activation versus mindfulness-based guided self-help treatment administered through a smartphone application: a randomised controlled trial. BMJ Open. 2014 Jan 9;4(1):e003440. doi: 10.1136/bmjopen-2013-003440.
- Ly KH, Carlbring P, Andersson G. Behavioral activation-based guided self-help treatment administered through a smartphone application: study protocol for a randomized controlled trial. Trials. 2012 May 18;13:62. doi: 10.1186/1745-6215-13-62.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
February 1, 2012
Primary Completion (Actual)
April 1, 2013
Study Completion (Actual)
May 1, 2013
Study Registration Dates
First Submitted
October 28, 2011
First Submitted That Met QC Criteria
October 31, 2011
First Posted (Estimate)
November 1, 2011
Study Record Updates
Last Update Posted (Estimate)
June 19, 2013
Last Update Submitted That Met QC Criteria
June 18, 2013
Last Verified
June 1, 2013
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- GA-PC-KHL
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Depression
-
Massachusetts General HospitalRecruitingDepression | Depression - Major Depressive Disorder | Depression Chronic | Depression in Adults | Depression Disorders | Depression DisorderUnited States
-
University of California, San FranciscoNational Center for Complementary and Integrative Health (NCCIH)Active, not recruitingDepression Moderate | Depression Mild | Depression, TeenUnited States
-
ProgenaBiomeWithdrawnDepression | Depression, Postpartum | Depression, Anxiety | Depression Moderate | Depression Severe | Clinical Depression | Depression in Remission | Depression, Endogenous | Depression ChronicUnited States
-
Sorlandet Hospital HFUniversity of Oslo; Karolinska Institutet; Australian Catholic University; Helse...RecruitingAnxiety | Anxiety Depression | Depression Anxiety Disorder | Depression - Major Depressive DisorderNorway
-
Lipocine Inc.CompletedDepression, Postpartum | Postnatal Depression | Peripartum Depression | Depression, Post-Partum | Postpartum Depression (PPD) | Post-Natal DepressionUnited States
-
Washington University School of MedicineCompletedTreatment Resistant Depression | Late Life Depression | Geriatric Depression | Refractory Depression | Therapy-Resistant DepressionUnited States, Canada
-
Kintsugi Mindful Wellness, Inc.Sonar Strategies; Vituity PsychiatryActive, not recruitingDepression | Depression Moderate | Depression Severe | Depression MildUnited States
-
Kintsugi Mindful Wellness, Inc.Sonar Strategies; Kolby Walker, DO; Brittany KimbleRecruitingDepression | Depression Moderate | Depression Severe | Depression MildUnited States
-
University of CincinnatiNational Center for Complementary and Integrative Health (NCCIH)RecruitingMild DepressionUnited States
-
University of MinnesotaCompletedDepression SymptomsUnited States
Clinical Trials on Smartphone delivered BA
-
The Hong Kong Polytechnic UniversityRecruiting
-
Fred Hutchinson Cancer CenterNational Cancer Institute (NCI); University of WashingtonCompleted
-
Massachusetts General HospitalNational Institute of Mental Health (NIMH)Not yet recruitingA Randomized Controlled Trial of a Smartphone Delivered Treatment for Suicidal Thoughts and BehaviorSuicidal Ideation | Suicide AttemptUnited States
-
Massachusetts General HospitalKoa Health B.V.WithdrawnSocial Anxiety DisorderUnited States
-
Massachusetts General HospitalKoa Health B.V.WithdrawnMajor Depressive DisorderUnited States
-
Koa Health B.V.Massachusetts General HospitalActive, not recruitingBody Dysmorphic DisordersUnited States
-
The University of Hong KongRecruitingDepressive SymptomsHong Kong
-
Massachusetts General HospitalTelefónica S.A.WithdrawnMajor Depressive DisorderUnited States
-
Massachusetts General HospitalTelefónica S.A.WithdrawnObsessive-Compulsive DisorderUnited States
-
Massachusetts General HospitalKoa Health B.V.Completed